Ann-Christin Eder

Title: Ann-Christin Eder: Innovator in Molecular Imaging

Introduction

Ann-Christin Eder is a prominent inventor based in Simonswald, Germany. She has made significant contributions to the field of molecular imaging, particularly in the detection of neoplastic cells. With a total of 3 patents to her name, her work is paving the way for advancements in medical diagnostics.

Latest Patents

One of her latest patents is titled "Double-labeled probe for molecular imaging and use thereof." This invention relates to a compound or a pharmaceutically acceptable salt that has a specific chemical structure designed to bind to cell membranes of neoplastic cells. The compound includes a motif that specifically targets these cells, a chelator moiety for radiometals, and a dye moiety. The invention also encompasses methods for detecting neoplastic cells in vitro using these compounds or compositions.

Another patent under the same title further elaborates on the compound's structure, emphasizing the importance of the spacers that connect the various components of the molecule. This innovative approach enhances the efficacy of detecting neoplastic cells, which is crucial for early diagnosis and treatment.

Career Highlights

Throughout her career, Ann-Christin Eder has worked with esteemed institutions such as the Deutsches Krebsforschungszentrum and Ruprecht-Karls-Universität Heidelberg. Her experience in these organizations has allowed her to collaborate with leading experts in cancer research and molecular imaging.

Collaborations

Some of her notable coworkers include Matthias Eder and Klaus Kopka. Their collaborative efforts have contributed to the success of her research and the development of her patented technologies.

Conclusion

Ann-Christin Eder is a trailblazer in the field of molecular imaging, with her innovative patents significantly impacting cancer diagnostics. Her work continues to inspire advancements in medical technology and research.